Medicare Enrolled

Dr. Rabia Parveez, MD

Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
7130 N MILLBROOK AVE, Fresno, CA 93720
5593261222
Registered in NPPES since 2006
NPI: 1922055680 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parveez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parveez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Parveez

Dr. Rabia Parveez is a hematology & oncology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Parveez performed 193,501 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Parveez received a total of $26,371 from 54 pharmaceutical and/or device companies across 423 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Parveez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 3% volume in CA $26,371 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
193,501
Medicare services
Top 3% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
58,500 $1 $9
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
47,900 $2 $12
Filgrastim-ayow biosimilar injection, 1 microgram
An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram.
36,180 $0 $2
Anti-nausea injection (aprepitant) 7,540 $1 $11
Oxaliplatin chemotherapy injection
This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg.
6,800 $0 $8
Nivolumab injection (Opdivo) 6,660 $24 $72
Denosumab injection (Prolia/Xgeva) 4,500 $18 $51
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
3,330 $36 $118
Injection, granisetron, extended-release, 0.1 mg 3,300 $5 $20
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
3,175 $0 $1
Iron infusion (Monoferric) 2,100 $16 $62
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,738 $8 $11
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,738 $8 $20
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,243 $0 $8
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
819 $11 $40
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
794 $97 $418
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
788 $10 $27
Injection, leucovorin calcium, per 50 mg 518 $3 $13
Anti-nausea injection (Aloxi/palonosetron) 440 $1 $10
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
435 $2 $10
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
359 $13 $35
Iron level test 345 $6 $17
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
344 $9 $22
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
344 $67 $286
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
296 $1 $10
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
285 $24 $87
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
247 $142 $558
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
231 $96 $252
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
213 $51 $198
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
198 $110 $400
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
176 $15 $38
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
173 $14 $37
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
133 $1 $9
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
127 $4 $11
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
114 $1 $2
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
105 $24 $84
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
90 $17 $61
Immunoglobulin level test
A blood test that measures the level of gammaglobulins, which are immune system proteins.
89 $9 $24
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
86 $61 $222
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
69 $1,360 $4,921
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
68 $140 $521
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 65 $285 $898
Electrophoresis laboratory test
A laboratory testing technique that separates molecules based on their size and electrical charge.
63 $59 $154
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
61 $55 $194
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
56 $50 $145
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
55 $4 $14
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
54 $120 $450
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
49 $13 $47
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
43 $4 $12
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
43 $29 $90
Haptoglobin level test
A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown.
41 $12 $32
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
39 $77 $375
Automated red blood cell count
An automated laboratory test that measures the number of red blood cells in a blood sample.
34 $4 $10
Prolonged intravenous chemotherapy administration
This procedure involves the administration of chemotherapy medication directly into a vein over an extended period.
32 $107 $410
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
32 $48 $256
Carcinoembryonic antigen (CEA) level test
A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer.
31 $19 $48
Concurrent intravenous infusion
Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given.
31 $17 $58
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
29 $47 $171
New patient office visit, complex (60-74 min) 27 $171 $594
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
22 $248 $943
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
20 $6 $16
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
17 $16 $42
Coagulation assessment blood test
A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood.
15 $6 $16
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
14 $4 $11
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
13 $123 $628
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
13 $32 $307
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
12 $72 $153
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.5% high complexity
62.2% medium
4.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$26,371
Total received (2018-2024)
Avg $3,767/year across 7 years
Top 17% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
423
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,916
2023
$1,179
2022
$1,710
2021
$9,683
2020
$5,993
2019
$5,875
2018
$14

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$246
Celgene Corporation
$242
GlaxoSmithKline, LLC.
$202
Exelixis Inc.
$134
Daiichi Sankyo Inc.
$130
ABBVIE INC.
$124
Novartis Pharmaceuticals Corporation
$101
Lilly USA, LLC
$76
Takeda Pharmaceuticals U.S.A., Inc.
$67
Ipsen Biopharmaceuticals, Inc
$60
Merck Sharp & Dohme LLC
$59
PFIZER INC.
$57
Regeneron Healthcare Solutions, Inc.
$55
SOBI, INC
$46
E.R. Squibb & Sons, L.L.C.
$43
EMD Serono, Inc.
$42
BeiGene USA, Inc.
$36
Sirtex Medical Inc
$35
SERVIER PHARMACEUTICALS LLC
$34
Pharmacosmos Therapeutics Inc.
$30
Eisai Inc.
$25
Incyte Corporation
$22
Janssen Biotech, Inc.
$20
Genentech USA, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$7,217
Acceleron Pharma, Inc.
$3,160
Pharmacosmos Therapeutics Inc.
$2,430
Karyopharm Therapeutics Inc.
$2,334
E.R. Squibb & Sons, L.L.C.
$2,206
Exelixis Inc.
$1,890
Epizyme, Inc.,
$1,263
Rigel Pharmaceuticals, Inc.
$1,200
AstraZeneca Pharmaceuticals LP
$590
Daiichi Sankyo Inc.
$440
Novartis Pharmaceuticals Corporation
$381
GlaxoSmithKline, LLC.
$343
Kite Pharma, Inc.
$224
Astellas Pharma US Inc
$200
Regeneron Healthcare Solutions, Inc.
$145
Takeda Pharmaceuticals U.S.A., Inc.
$143
Janssen Biotech, Inc.
$135
Clovis Oncology, Inc.
$135
Pharmacyclics LLC, An AbbVie Company
$128
Amgen Inc.
$127
ABBVIE INC.
$124
Ipsen Biopharmaceuticals, Inc
$121
Lilly USA, LLC
$115
Incyte Corporation
$113
Merck Sharp & Dohme LLC
$88
TerSera Therapeutics LLC
$84
PFIZER INC.
$74
SOBI, INC
$72
Pharmacyclics LLC, an AbbVie Company
$70
EMD Serono, Inc.
$65
BeiGene USA, Inc.
$64
Gilead Sciences, Inc.
$56
SANOFI-AVENTIS U.S. LLC
$55
Alexion Pharmaceuticals, Inc.
$54
Merck Sharp & Dohme Corporation
$54
GENZYME CORPORATION
$47
Sirtex Medical Inc
$43
Genentech USA, Inc.
$43
Eisai Inc.
$36
Myovant Sciences Inc.
$35
SERVIER PHARMACEUTICALS LLC
$34
Seagen Inc.
$32
Acrotech Biopharma LLC
$28
Sobi, Inc
$28
Dova Pharmaceuticals
$18
PUMA BIOTECHNOLOGY, INC.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Apellis Pharmaceuticals, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
PharmaEssentia USA Corporation
$14
EISAI INC.
$13
TESARO, Inc.
$12
Advanced Accelerator Applications
$11
Top 3 companies account for 48.6% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · NINLARO · Neulasta · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PLUVICTO · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Reblozyl · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · Tavalisse · Tazverik · Tibsovo · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · XGEVA · XPOVIO · YERVOY · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Fresno?
Compare hematology & oncology specialists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
28
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Parveez is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Parveez experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Parveez performed 58,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Parveez receive payments from pharmaceutical companies?
Yes. Dr. Parveez received a total of $26,371 from 54 companies across 423 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parveez's costs compare to other hematology & oncology specialists in Fresno?
Dr. Parveez's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parveez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →